Package 51662-1250-1

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "ef6a784b-3d13-da51-e053-2a95a90ad05d", "openfda": {"unii": ["4182431BJH"], "rxcui": ["1670353"], "spl_set_id": ["763b549d-9b78-09dd-e053-2a91aa0aec7f"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 VIAL, SINGLE-DOSE (51662-1250-1)", "package_ndc": "51662-1250-1", "marketing_start_date": "20180919"}], "brand_name": "PHENYTOIN SODIUM", "product_id": "51662-1250_ef6a784b-3d13-da51-e053-2a95a90ad05d", "dosage_form": "INJECTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51662-1250", "generic_name": "PHENYTOIN SODIUM", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHENYTOIN SODIUM", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA084307", "marketing_category": "ANDA", "marketing_start_date": "20180919", "listing_expiration_date": "20261231"}